PMDA drug package insert
太田胃散NEXT錠
PMDA OTC drug · 株式会社太田胃散 · package insert Sep 20, 2019
Key facts
| Brand names | 太田胃散NEXT錠 |
|---|---|
| Companies | 製造販売元／株式会社太田胃散 |
| Product type | OTC drug |
| OTC risk class | なし |
| OTC dosage form | 錠剤 |
| OTC effect category | 健胃薬 |
| Package insert date | Sep 20, 2019 |
| PMDA document key | 180061_K1909000008 |
| PMDA company code | 180061 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: